We are live on ! Find out more
Ameriprise

Ameriprise Portfolio holdings

AUM $495B
1-Year Est. Return 43.24%
 

Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.

This Fund
S&P 500
This Quarter Est. Return
+23.51%
1 Year Est. Return
+43.24%
3 Year Est. Return
+116.96%
5 Year Est. Return
+142.93%
10 Year Est. Return
+550.33%
AUM
$495B
AUM Growth
+$62.9B
Cap. Flow
-$2.24B
Cap. Flow %
-0.45%
Top 10 Hldgs %
19.63%
Holding
4,288
New
236
Increased
1,912
Reduced
1,831
Closed
191

Top Sells

Rank Stock Value
1
MRVL icon
Marvell Technology
MRVL
+$2.36B
2
BE icon
Bloom Energy
BE
+$1.22B
3
AMAT icon
Applied Materials
AMAT
+$1.17B
4
WDC icon
Western Digital
WDC
+$1.16B
5
LRCX icon
Lam Research
LRCX
+$1.05B

Sector Composition

Rank Sector Weight
1 Technology 27.59%
2 Miscellaneous 22.41%
3 Financials 9.69%
4 Industrials 8.9%
5 Healthcare 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCC
2501
CCC Intelligent Solutions
CCC
$4.06B
$5.05M ﹤0.01%
978,445
-131,741
-12% -$652K
AMP icon
2502
Ameriprise Financial
AMP
$43.5B
$5.05M ﹤0.01%
10,968
-459
-4% -$210K
ANRO icon
2503
Alto Neuroscience
ANRO
$1.04B
$5.04M ﹤0.01%
190,996
+177,672
+1,333% +$4.11M
DBL
2504
DoubleLine Opportunistic Credit Fund
DBL
$268M
$5.04M ﹤0.01%
350,374
+38,089
+12% +$548K
WAY
2505
Waystar Holding Corp
WAY
$4.74B
$5.03M ﹤0.01%
245,245
-51,007
-17% -$1.07M
EZM icon
2506
WisdomTree US MidCap Fund
EZM
$908M
$5.03M ﹤0.01%
66,417
+12,012
+22% +$870K
PPC icon
2507
Pilgrim's Pride
PPC
$6.62B
$5.03M ﹤0.01%
178,973
-56,330
-24% -$1.73M
CXW icon
2508
CoreCivic
CXW
$3.18B
$5.02M ﹤0.01%
165,090
-13,612
-8% -$309K
NTES icon
2509
NetEase
NTES
$73.9B
$5M ﹤0.01%
39,049
+5,931
+18% +$700K
PLAB icon
2510
Photronics
PLAB
$1.79B
$4.99M ﹤0.01%
153,502
+18,954
+14% +$802K
KLAC icon
2511
PUT
KLA
KLAC
$245B
$4.98M ﹤0.01%
16,500
+3,500
+27% +$695K
CRXP
2512
Columbia Core Plus Bond ETF
CRXP
$13.2M
$4.96M ﹤0.01%
248,959
– –
TRN icon
2513
Trinity Industries
TRN
$2.22B
$4.96M ﹤0.01%
143,301
-4,352
-3% -$147K
NIC icon
2514
Nicolet Bankshares
NIC
$3.53B
$4.95M ﹤0.01%
29,947
+28,575
+2,083% +$4.22M
PRVA icon
2515
Privia Health
PRVA
$2.52B
$4.91M ﹤0.01%
190,872
-5,643
-3% -$131K
TECX
2516
Tectonic Therapeutic
TECX
$463M
$4.9M ﹤0.01%
142,448
-984
-0.7% -$28.9K
UEIC icon
2517
Universal Electronics
UEIC
$66M
$4.89M ﹤0.01%
1,026,032
+152,381
+17% +$634K
BIO icon
2518
Bio-Rad Laboratories Class A
BIO
$10.2B
$4.89M ﹤0.01%
16,649
-1,374
-8% -$390K
FRME icon
2519
First Merchants
FRME
$2.56B
$4.88M ﹤0.01%
111,740
-2,735
-2% -$111K
EIG icon
2520
Employers Holdings
EIG
$850M
$4.87M ﹤0.01%
96,542
-4,616
-5% -$202K
RIVN icon
2521
Rivian
RIVN
$22.4B
$4.85M ﹤0.01%
279,684
+7,808
+3% +$122K
PROV icon
2522
Provident Financial
PROV
$115M
$4.85M ﹤0.01%
281,949
-878
-0.3% -$14.9K
LFST icon
2523
Lifestance Health
LFST
$4.5B
$4.85M ﹤0.01%
452,546
+346,659
+327% +$2.68M
FDT icon
2524
First Trust Developed Markets ex-US AlphaDEX Fund
FDT
$1.36B
$4.83M ﹤0.01%
+51,043
New +$4.88M
LCII icon
2525
LCI Industries
LCII
$2.05B
$4.83M ﹤0.01%
45,632
-24,859
-35% -$2.73M

Similar funds

Ameriprise's Q2 2026 Portfolio in Review

As of Q2 2026, Ameriprise held 4,288 positions worth $495B, up 15% from $432B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Ameriprise's Q2 2026 filing shows 236 new, 1,912 increased, 1,831 reduced and 191 closed positions. Its largest new stake was Honeywell Aerospace: 3,351,052 shares worth $741M. The largest sale was Marvell Technology, an estimated $2.36B.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Miscellaneous and Financials.

  • Ameriprise's largest Q2 2026 buy was Honeywell Aerospace: 3,351,052 shares worth $741M.
  • Ameriprise added most to iShares Russell 1000 Value ETF in Q2 2026, an estimated $1.74B increase.
  • Ameriprise's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $2.36B.
  • Ameriprise fully exited Coterra Energy in Q2 2026, selling an estimated $63.9M.
  • Ameriprise's ten largest holdings make up 20% of its $495B portfolio in Q2 2026.
  • Ameriprise opened 236 new positions and closed 191 in Q2 2026.
  • Ameriprise's portfolio value rose 15% quarter-over-quarter to $495B.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.